← Leaderboards
Jorge G Gomez-Gutierrez
University Of Louisville
$1,600,393
Attributed
$1,600,393
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $470.5K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,600,393 · 4
By mechanism
R21$1,129,935 · 3
R01$470,458 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- Esma S Yolcu$2,168,034
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoSignal TransductionMalignant NeoplasmsIn VitroTumorCellsImageGenerationsImmuneCostFoundationsGene DeliveryGene TherapyHypoxiaClinicCytokineCancer ModelCancer ImmunotherapyCell DeathCancer PatientAgonistColorDyesBacteria
Grant awards (5)
Enhancing anti-PD-1 blockade antitumor efficacy by oncolytic virotherapy-mediated tumor microenvironment immunomodulation$409,158
R21 · FY2025 · CA · contact PI
Bioengineering probiotic bacterium contrast agents for monitoring of inflammation using multispectral optoacoustic tomography$470,458
R01 · FY2024 · EB · contact PI
Oncolytic Adenovirus Armed with SA-4-1BBL Immune Checkpoint Stimulator for Lung Cancer Immunotherapy$352,332
R21 · FY2021 · CA · contact PI
Targeting melanoma hypoxia with lactic acid bacterium L. lactis$167,475
R21 · FY2018 · CA · contact PI
Targeting melanoma hypoxia with lactic acid bacterium L. lactis$200,970
R21 · FY2017 · CA · contact PI